Instructors can request access to the Casebook Instructor's Guide on AccessPharmacy. Email User Services (email@example.com) for more information.
After completing this case study, the reader should be able to:
Recognize the signs and symptoms of heart failure.
Develop a pharmacotherapeutic plan for treatment of heart failure with reduced ejection fraction (HFrEF).
Outline a monitoring plan for heart failure that includes both clinical and laboratory parameters.
“I’ve been more short of breath lately. I can’t seem to walk as far as I used to, and either my feet are growing or my shoes are shrinking!”
Rosemary Quincy is a 68-year-old African-American woman who presents to her family medicine physician for evaluation of her shortness of breath and increased swelling in her lower extremities. She reports that her shortness of breath has been gradually increasing over the past 4 days. She has noticed that her shortness of breath is particularly worse when she is lying in bed at night, and she has to prop her head up with three pillows in order to sleep. She also reports exertional dyspnea that is usual for her, but especially worse over the past couple of days.
CHD with history of MI in 2005 (PCI performed and bare metal stents placed in LAD and RCA)
Heart failure (NYHA FC III)
Father died of lung cancer at age 71, mother died of MI at age 73.
Reports occasional alcohol intake. States she has been trying to follow her low-cholesterol and low-sodium diet. Former smoker (35 pack-year history; quit approximately 10 years ago).
Warfarin 2.5 mg PO once daily
Carvedilol 3.125 mg PO BID
Pioglitazone 30 mg PO once daily
Glimepiride 2 mg PO once daily
Potassium chloride 20 mEq PO once daily
Atorvastatin 40 mg PO once daily
Aspirin 81 mg PO once daily
Albuterol MDI, two inhalations by mouth q 4–6 hours PRN shortness of breath
Tiotropium DPI 18 mcg, one inhalation by mouth daily
Fluticasone/salmeterol DPI 250 mcg/50 mcg, one inhalation by mouth BID